True Wealth Design’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.4K Sell
332
-9
-3% -$876 0.01% 728
2026
Q2
$36.5K Hold
341
– – 0.01% 603
2026
Q1
$110 Buy
341
+88
+35% +$1.42K ﹤0.01% 2455
2025
Q4
$4.37K Buy
+253
New +$4.91K ﹤0.01% 1142
2025
Q3
– Sell
-2
Closed -$92 – 2718
2025
Q2
$92 Sell
2
-29
-94% -$2.33K ﹤0.01% 2259
2025
Q1
$3.31K Buy
+31
New +$2.7K ﹤0.01% 820
2024
Q1
– Hold
0
– -$26 – 788
2023
Q4
– Hold
0
– – – 773
2023
Q3
– Hold
0
– – – 733
2023
Q2
– Hold
0
– – – 774
2023
Q1
– Hold
0
– – – 853
2022
Q4
– Hold
0
– – – 799

Other funds holding AGL

True Wealth Design's AGL Position: Q3 2026 in Review

True Wealth Design reduced its Agilon Health (AGL) stake by 2.6% in Q3 2026, selling an estimated $876 and leaving 332 shares worth $26.4K. The position accounts for 0.01% of the portfolio, ranked #728.

True Wealth Design first reported a position in AGL in Q1 2025 and has held it in 6 quarters since. The position peaked at $36.5K in Q2 2026. 6 funds tracked by Wall St. Rank hold AGL as of Q3 2026.

  • True Wealth Design held 332 shares of Agilon Health worth $26.4K as of Q3 2026.
  • True Wealth Design sold 9 Agilon Health shares in Q3 2026, an estimated $876.
  • Agilon Health made up 0.01% of True Wealth Design's portfolio in Q3 2026, its #728 holding.
  • True Wealth Design first reported a position in Agilon Health in Q1 2025 and has held it in 6 quarters since.
  • True Wealth Design's Agilon Health position peaked at $36.5K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Agilon Health as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.